Segments - Protein Stain Market by Type (Protein Staining Device and Reagents (Stain Type)), by Application (Protein Separation, Protein Analysis, and Others), by End-user (Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, Contract Research Organizations, and Others) and Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
The Global Protein Stain Market was valued at USD 119.09 Million in 2023 and is projected to reach USD 219.83 Million by 2032, expanding at a CAGR of 7.3% during the forecast period. The growing demand for understanding protein structure, function, and interactions has led to a rise in research activities in life sciences. Protein stains play a crucial role in these studies, driving the market growth.
Protein stains are specialized dyes or ligands employed to visualize proteins separated by techniques such as gel electrophoresis. The post-separation visualization allows for the analysis of protein size, quantity, and distribution within the gel matrix. Protein staining is an essential step in protein analysis, enabling researchers to visualize, quantify, and characterize proteins separated by gel electrophoresis reagents. Researchers gain valuable insights into protein expression, localization, and function within biological systems by selecting the appropriate staining method.
Different types of dyes used by researchers to stain proteins include Coomassie stains, silver stains, zinc stains, and fluorescent dyes and stains. Coomassie stain is the most widely used protein stain, as it is affordable and easy to use. Coomassie efficiently renders proteins a vibrant blue. Silver stain is a more sensitive stain than Coomassie stain. It is used to detect small amounts of protein. Fluorescent stain is used to detect proteins that are not visible with other stains. It is used to stain multiple proteins and visualize at the same time.
The research report finds that the outbreak of COVID-19 pandemic had a negative impact on the market. Lockdowns and social distancing measures led to the closure of some research labs or reduced staffing, impacting research activities that rely on protein stains. Many research labs shifted their focus on studying the SARS-CoV-2 virus and developing vaccines and therapeutics, leading to a temporary decline in demand for protein stains used in other research areas. Disruptions in transportation networks and border closures caused delays in the delivery of raw materials and finished protein stains, impacting research timelines and workflows.
Artificial Intelligence (AI) impacted the global protein stain market in a positive way. AI-powered image analysis automate protein staining protocols, reducing human error and improving consistency. AI algorithms analyze complex protein-stain interactions, leading to the development of more specific and sensitive stains. AI analyze protein expression patterns in diseased tissues, aiding in biomarker identification and drug target discovery. AI-assisted protein staining accelerates pre-clinical trials by providing faster and more accurate data on drug efficacy.
GDP growth rate of a country, the overall economic growth, and stability of countries significantly impact the market across the globe. High GDP growth rates lead to increased healthcare spending, including investments in hospital infrastructure, medical devices, and other supplies. Emerging economies, such as Russia, India, and China, the UAE, and other countries in Southeast Asia and Latin America, are key destinations for the healthcare industry. The economic growth of emerging countries is growing by about 6% annually, whereas countries with an already well-established economy report growth rate below 3%. In 2021, the total contribution of the healthcare industry to the global GDP was 10%. Israel is the second-largest economy in the Middle East & North Africa (MENA) with a GDP of USD 488 billion in 2022. Saudi Arabia is with USD 1,108.1 billion GDP in 2022.
The healthcare industry is set to grow in the coming years with the rising population and adding new health centers. The demand for healthcare services globally has increased rapidly in the recent years, due to the high prevalence of chronic and non-communicable diseases. The global healthcare industry is projected to expand at a compound annual growth rate (CAGR) of 8.6% from 2022 to 2027. High spending by governments and increasing involvement of the private sector have helped boosted the demand and improved the quality of healthcare infrastructure. In October 2022, the Saudi Arabia Health Ministry announced to approve 100 projects by 2027, which are undertaken in cooperation with the private sector. The deals are estimated to be worth around USD 12.8 billion. The medical technology industry registered an average global investment rate (R&D spending as a proportion of sales) of 11% in 2021.
Growing importance of proteomics research in understanding protein function, disease mechanisms, and drug development is boosting the demand for protein stains. Proteins are the workhorses of cells, and studying their interactions and modifications provides a deep understanding of biological processes. Protein stains facilitate protein visualization and analysis, which are crucial for proteomic studies. Proteomics identifies disease biomarkers, aiding in the diagnosis and development of targeted therapies. Increasing government funding for proteomics research and life sciences initiatives is creating a favourable environment for the protein stain market expansion. Regulatory bodies are encouraging the development of advanced protein staining techniques, which propels the market. Thus, the rising demand for protein stains in proteomics research is expected to drive the market in the coming years.
The pharmaceutical and biotechnology industries are significantly investing in R&D activities, leading to increased demand for protein staining tools and techniques. Pharmaceutical companies are increasing their R&D budgets to maintain a competitive edge. Growing venture capital funding for biotech startups, government initiatives, and public-private partnerships supporting R&D are also boosting the demand for protein stains. Collaboration between pharmaceutical companies, academic institutions, and biotech startups has increased from 2019 to 2023.
The rising R&D activities in the pharmaceutical and biotech industries signify a crucial shift toward developing innovative and targeted therapies for unmet medical needs. This growth in R&D is driven by technological advancements, increasing investment, and a focus on personalized medicine. Thus, the rising R&D activities in the pharmaceutical and biotech industries are projected to drive the market in the coming years.
The high cost of protein stains and equipment reduces accessibility and limits the widespread adoption of protein staining techniques, particularly in resource-constrained settings. Protein stains, especially high-sensitivity stains such as silver staining, are costly, impacting the overall budget of research labs and Contract Research Organizations (CROs). High costs deter research labs from utilizing protein stains extensively. This limits research opportunities and hinders scientific advancements.
Certain staining techniques require specialized equipment such as light chambers and incubators, adding to the initial investment cost. Expensive equipment and reagents discourage the adoption of new, highly sensitive, or specialized protein staining technologies. High costs associated with protein stains significantly increase research budgets, impacting the overall feasibility of research projects. Thus, the high cost of reagents and equipment is expected to restrain the market in the coming years.
Research & development (R&D) is essential for economic growth, as it encourages innovation, invention, and progress. Investments have increased innovations in the healthcare industry in recent times. Continuous investment in the R&D of medical equipment fosters competitive advantages. In the US, medical and health research & development (R&D) investment reached USD 245.1 billion in 2020, an 11.1% increase from 2019. Medical device companies are investing heavily in research & development to continually improve their products and stay ahead of the competition. This, in turn, contributes to the evolution of protein stains and equipment, ensuring continuous improvements in the medical field. This further improves the effectiveness and comfort of treatment. Thus, the rising investment in R&D creates lucrative opportunities in the market, as it benefits patients and reinforces the healthcare industry.
The report on the global protein stain market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Protein Stain Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast |
Base Year |
2023 |
Historic Data |
2017-2022 |
Forecast Period |
2024–2032 |
Segmentation |
by Type (Protein Staining Device and Reagents (Stain Type)), by Application (Protein Separation, Protein Analysis, and Others), by End-user (Biotechnology & Pharmaceutical Companies, Academic & Research Institutes, Contract Research Organizations, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered |
Abbkine, Inc.; ApexBio Technology; Bio-Rad Laboratories, Inc.; Bio-Techne (Tocris Bioscience); Biotium; Bulldog-Bio; FUJIFILM Holdings Corporation; GenScript; LI-COR Biotech, LLC; LOBA CHEMIE PVT. LTD.; MBL International Corporation (MBLI); Merck KGaA; Orochem Technologies Inc.; Sangon Biotech (Shanghai) Co., Ltd. (BBI Life Sciences); and Thermo Fisher Scientific Inc. |
Based on type, the protein stain market is segmented into protein staining device and reagents (stain type). The reagents (stain type) segment is further subdivided into coomassie stains, silver stains, fluorescent stains, and stain-free technology. The Reagents (stain type) segment is anticipated to hold significant market share in the 2023, as reagents provide a sensitive, environmentally friendly, and efficient protein staining solution.
The protein staining device segment is expected to expand at a considerable CAGR during the forecast period, as it represents a significant advancement in protein gel staining technology.
On the basis of by application, the protein stain market is classified as protein separation, protein analysis, and others. The protein separation segment is anticipated to hold a substantial share of the market in 2023, as protein staining is an essential tool in protein separation techniques, enabling researchers to visualize, quantify, and characterize proteins.
The protein analysis segment is expected to hold significant CAGR during the forecast period. Protein stain is crucial for analyzing proteins separated by electrophoresis. Protein analysis includes protein detection, protein identification and protein quantification.
On the basis of region, the global Protein Stain market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The market in North America holds the significant share due to rising research activities in proteomics and life sciences in the region. Growing demand for sensitive and specific protein detection methods in North America is expected to contribute to the growth of the market in the coming years. Increased investment in healthcare research and development activities in the US and Canada is projected to create a strong demand for protein analysis tools.
The market in Europe is expected to grow at a rapid pace during the forecast period due to rising demand for protein analysis in various research and development applications. Continuous advancements in staining technologies and ongoing investments in R&D are expected to further propel the market in the coming years.
The market in Asia- Pacific is projected to hold a considerable share of the market in the coming years owing to rapidly developing biotechnology sector and increasing government support for R&D in the region.
Manufacturer operating in the global protein stain market include Abbkine, Inc.; ApexBio Technology; Bio-Rad Laboratories, Inc.; Bio-Techne (Tocris Bioscience); Biotium; Bulldog-Bio; FUJIFILM Holdings Corporation; GenScript; LI-COR Biotech, LLC; LOBA CHEMIE PVT. LTD.; MBL International Corporation (MBLI); Merck KGaA; Orochem Technologies Inc.; Sangon Biotech (Shanghai) Co., Ltd. (BBI Life Sciences); and Thermo Fisher Scientific Inc.
On February 2024, Biotium, a leader in fluorescent dyes for life science research, announced the expansion of its NucSpot Nuclear Stains lineup, offering unprecedented specificity and flexibility for nuclear counterstaining. NucSpot Nuclear Stains are membrane-impermeant, targeting the nucleus selectively with minimal fluorescence until binding to DNA, enabling convenient no-wash nuclear staining.
On February 2017, Abbkine, Inc. announced the release of Protein Gel Flash Staining Kit. The Protein Gel Flash Staining Kit is another product from Abbkine, Inc. and the kit is made to be a safe, fast, and sensitive solution for visualizing protein bands on polyacrylamide gels. The kit, a one 5X stock staining reagent, is a protein staining kit made to deliver different ranges of 10ng to 5μg in less than an 1 hour.
Additional company profiles can be provided on request. For a discussion related to above findings, click Speak to Analyst.
Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.
Increasing application of stains in diagnostics, increasing research and development in life sciences and Rising demand for personalized medicine are some of the factors expected to drive the market growth during the forecast period.
According to this growth market report, the global protein stain market is likely to register a CAGR of 7.3 % during the forecast period 2024-2032, with an anticipated valuation of USD 219.83 Million by the end of 2032.
Healthcare industry and pharma industry are the major industry of Protein Stain.
Factors such as rising GDPs of emerging economies, R&D activities, and healthcare expenditure are analyzed in the final report.
The pandemic had a negative impact on the global Protein Stain market. Lockdowns and social distancing measures led to the closure of some research labs or reduced staffing, impacting research activities that rely on protein stains.
In addition to market size (in USD Million), company market share (in % for base year 2023), and value have been provided in the report.
The base year considered for the global protein stain market report is 2023. The complete analysis period is 2017 to 2032, wherein, 2017-2022 are the historic years, and forecast is provided from 2024 to 2032.